7Baggers
 CytoMed Therapeutics Unveils Promising AML Therapy Research  TipRanks Thu, 02 Oct 2025 17:28:20 GMT
 CytoMed reports promising preclinical results for leukemia treatment  Investing.com India Thu, 02 Oct 2025 11:24:00 GMT
 published on: 2025-09-18 19:07:16  خودرو بانک Thu, 18 Sep 2025 15:39:21 GMT
 published on: 2025-09-17 21:48:09  newser.com Thu, 18 Sep 2025 02:48:09 GMT
 published on: 2025-09-12 06:18:46  Newser Fri, 12 Sep 2025 11:18:46 GMT
 published on: 2025-09-12 00:42:12  Newser Fri, 12 Sep 2025 05:42:12 GMT
 published on: 2025-09-09 06:10:58  Newser Tue, 09 Sep 2025 11:10:58 GMT
 published on: 2025-09-05 22:03:59  خودرو بانک Fri, 05 Sep 2025 22:08:51 GMT
 published on: 2025-09-02 18:22:48  خودرو بانک Tue, 02 Sep 2025 07:00:00 GMT
 published on: 2025-09-02 00:41:13  خودرو بانک Mon, 01 Sep 2025 21:11:28 GMT
 Update on recent acquisition - CytoMed Therapeutics expands  GlobeNewswire Thu, 28 Aug 2025 07:00:00 GMT
 cytomed therapeutics expanded into auto-immune diseases  TipRanks Thu, 28 Aug 2025 07:00:00 GMT
 published on: 2025-08-28 04:02:39  beatles.ru Thu, 28 Aug 2025 01:04:11 GMT

CytoMed Therapeutics Limited
(NASDAQ:GDTC) 

GDTC stock logo

CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers. The company's lead product candidate is CTM-N2D, which consists of expanded gamma delta T cells grafted with natural killer group 2D liga...

Founded: 2018
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends